TAYLER LEGGETT: Open Payments
NPI 1376067835 · SILSBEE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,605 in 69 payments from 16 companies in 2025. Trend: 2023 $1,000 · 2024 $564 · 2025 $1,605
Food & beverage: $1,495Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $468 |
| ABBVIE INC. | 17 | $308 |
| Novartis Pharmaceuticals Corporation | 9 | $186 |
| UCB, Inc. | 5 | $159 |
| Regeneron Healthcare Solutions, Inc. | 3 | $107 |
| GENZYME CORPORATION | 3 | $73 |
| Mallinckrodt Hospital Products Inc. | 3 | $62 |
| Lilly USA, LLC | 2 | $48 |
| Journey Medical Corporation | 1 | $43 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
Products named: TREMFYA, RINVOQ, COSENTYX, Bimzelx, DUPIXENT, SKYRIZI, ACTHAR, Zoryve.
Industry payments across TX — which companies pay providers there.
